BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 1997
View Archived Issues
Growth hormone antagonist enters phase II
Read More
Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies
Read More
GEM-92 enters clinical trials for AIDS
Read More
KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH
Read More
KRN-4884 active in several preclinical models of hypertension
Read More
Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats
Read More
Anticonvulsant profile of two new GABA uptake inhibitors
Read More
Role of osteoprotegerin in skeletal metabolism elucidated
Read More
New anthraquinone interacting with telomeric G-quadruplex DNA
Read More
3-D database search at Schering-Plough leads to potent, selective FPT inhibitors
Read More
Dual ACE/NEP inhibitors described by Zambon
Read More
Fujisawa discloses new PDE IV/TNF inhibitors
Read More
Known antidiabetic agent modulates glucocorticoid response in osteoclasts
Read More
Retinoid-like compounds from Allergan
Read More
FDA panel recommends approval of Anesta's Actiq for cancer pain
Read More
Efavirenz/indinavir combination shows efficacy in phase II
Read More
Novel osteoclast resorption inhibitor isolated by Swiss investigators
Read More
New raloxifene analogue from Lilly is a potent SERM
Read More
Potent and selective N-type calcium channel blockers for stroke
Read More
Oxford GlycoSciences' OGT-719 enters clinical testing
Read More
TheraTech and Astra sign agreement for Androderm distribution
Read More
Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice
Read More
October launch for Zanaflex in U.K.
Read More
U.S. introduction for FemPatch
Read More
Asta Medica and Wyeth-Ayerst agreement for epilepsy drug
Read More
